Butorphanol (BC 2627)

Subscribe to Selected New Research on Butorphanol

334 relevant articles (54 outcomes, 53 trials/studies) found for this Drug

Description: A synthetic morphinan analgesic with narcotic antagonist action. It is used in the management of severe pain.

Also Known As:

BC 2627; Stadol; Stadol NS; 17-(Cyclobutylmethyl)morphinan-3,14-diol; Apo-Butorphanol; Apotex Brand of Butorphanol Tartrate; BC-2627; Beforal; Bristol-Myers Squibb Brand of Butorphanol Tartrate; Butorphanol Tartrate; Cephalon Brand of Butorphanol Tartrate; Dolorex; Fort Dodge Brand of Butorphanol Tartrate; Geneva Brand of Butorphanol Tartrate; Intervet Brand of Butorphanol Tartrate; Moradol; Torbugesic; BC2627; Morphinan-3,14-diol, 17-(cyclobutylmethyl)-

Relationship Network

Drug Context: Research Results

Experts

1.	Yosipovitch, Gil: 2 articles (01/2008 - 03/2006)
2.	Stern, Jessica L: 1 article (08/2008)
3.	Olsen, Jon C: 1 article (08/2008)
4.	Cutcliffe, Brian J: 1 article (08/2008)
5.	Schwarz, Dana G: 1 article (08/2008)
6.	McGrath, Norine A: 1 article (08/2008)
7.	Amagasa, S: 1 article (07/2008)
8.	Yokoo, N: 1 article (07/2008)
9.	Igarashi, A: 1 article (07/2008)
10.	Sato, M: 1 article (07/2008)

Related Diseases

1.	Pain (Aches) 10/01/1998 - "Understanding of this tolerance could make it butorphanol more effective in treating chronic visceral pain. " 10/14/2009 - "CONCLUSION: Butorphanol nasal spray is effective for the relief of pain after fistulectomy. " 10/01/2000 - "CONCLUSION: Stadol NS appears to be an effective treatment for moderate-to-severe pain after LA-UPPP. " 11/01/1995 - "Intranasal butorphanol is an opioid agonist-antagonist that is effective for the treatment of acute pain. " 01/01/1977 - "Butorphanol appears to be a safe and effective analgesic for the relief of moderate to severe post-operative pain." Order ALL the reference details at left...
2.	Postoperative Pain 12/01/2004 - "CONCLUSIONS: In contrast with placebo transnasal butorphanol was effective in the treatment of postoperative pain in female patients undergoing lower laparoscopic surgery. " 08/01/1998 - "Transnasal butorphanol is effective in relieving postoperative pain in adults and children. " 08/01/1998 - "Transnasal butorphanol is effective for postoperative pain relief in children undergoing myringotomy." 12/01/2004 - "The efficacy and safety of transnasal butorphanol for postoperative pain control following lower laparoscopic surgery." 08/01/1998 - "The effectiveness of transnasal butorphanol for postoperative pain management in children undergoing BMT was studied. " Order ALL the reference details at left...
3.	Migraine Disorders (Migraine) 01/01/1991 - "This study was undertaken to compare the effectiveness and safety of three dosage levels of butorphanol in 52 patients with acute, severe migraine headache. " 01/01/1997 - "Transnasal butorphanol in the emergency department management of migraine headache." 02/01/1995 - "Transnasal butorphanol in the treatment of acute migraine." 05/01/1994 - "New delivery systems, such as the nasal-spray formulation of butorphanol, allow for a route of administration previously unavailable to migraine sufferers. " 04/01/1993 - "Stadol Nasal Spray--treatment for migraine?" Order ALL the reference details at left...
4.	Pruritus (Itching) 10/01/1996 - "All patients reported significant relief from pruritus 60 min after butorphanol administration (P < 0.001); five patients noted an improvement within 15 min (P < 0.08). " 01/01/2008 - "This liposomal transdermal delivery formulation could serve as a method to deliver butorphanol for patients with chronic pruritus." 01/01/2008 - "In vitro and in vivo characterization of a novel liposomal butorphanol formulation for treatment of pruritus." 03/01/2006 - "Butorphanol for treatment of intractable pruritus." 10/01/1996 - "The use of intranasal butorphanol, an opioid agonist-antagonist, for pruritus has not been described previously. " Order ALL the reference details at left...
5.	Neoplasms (Cancer) 09/01/1993 - "The results of the clinical study of beforal (butorfanol) ("Spofa", Czechoslovakia), a synthetic analgetic from a class of opiate agonists-antagonists, in 17 cancer patients at all stages of surgical treatment have been summarized. " 03/01/1990 - "[Synthetic analgesic moradol at various stages of surgical treatment of patients with cancer]" 07/01/1983 - "[Clinical trial of butorphanol tartrate in cancer patients: evaluation for analgesic effects and safety on the basis of long term administration]" 01/01/1981 - "The safety, tolerance and analgesic efficacy of multiple oral doses of butorphanol tartrate for the long-term treatment of cancer pain were evaluated in this open study. " 10/01/1989 - "[Continuous infusion of butorphanol for pain in children with cancer]" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Morphine (MS Contin)
2.	Meperidine (Pethidine)
3.	Pentazocine (Talwin)
4.	Fentanyl (Sublimaze)
5.	dezocine
6.	Butorphanol (BC 2627)
7.	Droperidol
8.	Diazepam (Valium)
9.	Uric Acid (Urate)
10.	Liposomes (Liposome)

Related Therapies and Procedures

1.	Analgesia
2.	Cesarean Section (Caesarean Section)
3.	Injections
4.	Patient-Controlled Analgesia (Analgesia, Patient Controlled)
5.	Oral Surgery (Maxillofacial Surgery)

Best Treatments:
Research Summary Report
on Pain

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 9246 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>